Medical technology developer Compumedics (ASX:CMP) believes it is poised for accelerated growth in 2010 and beyond, through M&A activities and expansion into the European market.
In a presentation to investors, the company said it had a number of capital raising options, from the USA, Asia, Europe and the UK, and may also consider private equity funding.
The company estimates the market value for its existing core businesses to be up to US$500 million ($547.2 million) within the next three to five years.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.